AtriCure Inc Sustainability Reports
AtriCure, Inc. develops, manufactures, and sells innovative medical devices and technologies for surgical ablation, left atrial appendage management, and post-operative pain management. The company primarily targets treatments for atrial fibrillation and related cardiovascular conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900B2I6GPHK2EXM59
FIGI: BBG001SD43V3
11 reports from 2009 to 2026
